SNY
$53.88
Sanofi-Aventis Sa
$.07
.13%
SNY
Earnings Whisper ®
N/A
2nd Quarter June 2015
Consensus:  $0.72
Revenue:  N/A
Thursday
Jul 30
1:50 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when SNY reports earnings?
Beat
Meet
Miss

Where is SNY's stock price going from here?
Up
Flat
Down
Stock chart of SNY
Analysts
Summary of analysts' recommendations for SNY
Score
Grade
Pivots
Resistance
$54.74
$54.28
$54.05

$53.59

Support
$53.36
$52.90
$52.67
Tweet
Growth
Description
Sanofi-Aventis is a global pharmaceutical company that contributes to enhance life by providing medicines, vaccines, and integrated healthcare solutions adapted to local needs and means primarily in Europe and the United States. The company is engaged in the research, development, manufacture and marketing of healthcare products. Its strategy is built around three priorities to reach its goals and ensure sustainable growth. The priorities are: increasing innovation in Research and Development, adapting Group structures to future challenges and seizing external growth opportunities. Sanofi-Aventis specializes in six therapeutic areas: thrombosis, cardiovascular, metabolic disorders, oncology, central nervous system (CNS) and internal medicine. The Company offers vaccines in five areas: pediatric combination vaccines, influenza vaccines, adult and adolescent booster vaccines, meningitis vaccines, and travel and endemic vaccines. Sanofi-Aventis is headquartered in Paris, France.